IL-6-mediated environmental conditioning of defective Th1 differentiation dampens antitumour immune responses in old age

[1]  P. Nederlof,et al.  Immune-Escape Markers in Relation to Clinical Outcome of Advanced Melanoma Patients Following Immunotherapy , 2014, Cancer Immunology Research.

[2]  M. Ishii,et al.  Characterization of the IL-15 niche in primary and secondary lymphoid organs in vivo , 2014, Proceedings of the National Academy of Sciences.

[3]  M. Rothenberg,et al.  Eosinophils and Cancer , 2014, Cancer Immunology Research.

[4]  B. Fox,et al.  Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells , 2013, European journal of immunology.

[5]  L. Ferrucci,et al.  Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy , 2013, The Journal of experimental medicine.

[6]  B. Aggarwal,et al.  Curcumin improves the therapeutic efficacy of Listeriaat-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1 , 2013, Cancer medicine.

[7]  C. Weyand,et al.  Understanding immunosenescence to improve responses to vaccines , 2013, Nature Immunology.

[8]  João Pedro de Magalhães,et al.  How ageing processes influence cancer , 2013, Nature Reviews Cancer.

[9]  S. Senju,et al.  Myeloid-Derived Suppressor Cells Attenuate TH1 Development through IL-6 Production to Promote Tumor Progression , 2013, Cancer Immunology Research.

[10]  Bernd Hauck,et al.  Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. , 2013, The New England journal of medicine.

[11]  L. Zender,et al.  T-helper-1-cell cytokines drive cancer into senescence , 2013, Nature.

[12]  Jonathan B. Mitchem,et al.  Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. , 2013, Cancer research.

[13]  Robert M. DiFazio,et al.  IFN-γ from CD4 T Cells Is Essential for Host Survival and Enhances CD8 T Cell Function during Mycobacterium tuberculosis Infection , 2013, The Journal of Immunology.

[14]  U. V. von Andrian,et al.  CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. , 2012, Immunity.

[15]  Michael Tighe,et al.  The aged microenvironment contributes to the age‐related functional defects of CD4 T cells in mice , 2012, Aging cell.

[16]  Suzanne R. Thibodeaux,et al.  Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged mice. , 2012, Cancer research.

[17]  Steven A. Rosenberg,et al.  Adoptive immunotherapy for cancer: harnessing the T cell response , 2012, Nature Reviews Immunology.

[18]  C. Sautès-Fridman,et al.  The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.

[19]  Naveena Singh,et al.  Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer , 2011, Clinical Cancer Research.

[20]  I. Donaldson,et al.  Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer , 2011, Nature communications.

[21]  L. Sherman,et al.  CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes. , 2010, Cancer research.

[22]  S. Swain,et al.  Bim Dictates Naive CD4 T Cell Lifespan and the Development of Age-Associated Functional Defects , 2010, The Journal of Immunology.

[23]  E. Wherry,et al.  Cell-Intrinsic Defects in the Proliferative Response of Antiviral Memory CD8 T Cells in Aged Mice upon Secondary Infection , 2010, The Journal of Immunology.

[24]  N. Watanabe,et al.  c‐Maf activates the promoter and enhancer of the IL‐21 gene, and TGF‐β inhibits c‐Maf‐induced IL‐21 production in CD4+ T cells , 2010, Journal of leukocyte biology.

[25]  P. Muranski,et al.  Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma , 2010, The Journal of experimental medicine.

[26]  Peter Olson,et al.  Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. , 2010, Cancer cell.

[27]  L. S. Quinn,et al.  Serum and muscle interleukin-15 levels decrease in aging mice: Correlation with declines in soluble interleukin-15 receptor alpha expression , 2010, Experimental Gerontology.

[28]  S. Swain,et al.  Age-associated increase in lifespan of naïve CD4 T cells contributes to T-cell homeostasis but facilitates development of functional defects , 2009, Proceedings of the National Academy of Sciences.

[29]  A. Iwasaki,et al.  CTL mobilization to virus-infected tissue requires CD4+ T cell help , 2009, Nature.

[30]  S. Giovannini,et al.  Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction , 2009, Mechanisms of Ageing and Development.

[31]  C. Caruso,et al.  Inflammation, ageing and cancer , 2009, Mechanisms of Ageing and Development.

[32]  S. Anton,et al.  Molecular inflammation: Underpinnings of aging and age-related diseases , 2009, Ageing Research Reviews.

[33]  A. Iwasaki,et al.  CTL mobilization to virus-infected tissue requires CD4+ T cell help , 2009, Nature.

[34]  Y. Belkaid,et al.  Functional Regulatory T Cells Accumulate in Aged Hosts and Promote Chronic Infectious Disease Reactivation1 , 2008, The Journal of Immunology.

[35]  Jianhong Cao,et al.  Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. , 2008, The New England journal of medicine.

[36]  A. Merrill,et al.  Aging Up-Regulates Expression of Inflammatory Mediators in Mouse Adipose Tissue1 , 2007, The Journal of Immunology.

[37]  E. Cevenini,et al.  Age-dependent modifications of Type 1 and Type 2 cytokines within virgin and memory CD4+ T cells in humans , 2006, Mechanisms of Ageing and Development.

[38]  E. Gardner,et al.  Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population. , 2006, Vaccine.

[39]  S. Bandinelli,et al.  CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC only. TRIALS The , 2004 .

[40]  J. Ochando,et al.  IL-6 Plays a Unique Role in Initiating c-Maf Expression during Early Stage of CD4 T Cell Activation1 , 2005, The Journal of Immunology.

[41]  J. Berzofsky,et al.  Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function , 2005, The Journal of experimental medicine.

[42]  P. Allen,et al.  No Intrinsic Deficiencies in CD8+ T Cell-Mediated Antitumor Immunity with Aging1 , 2004, The Journal of Immunology.

[43]  S. Senju,et al.  Enhanced Priming of Antigen-Specific CTLs In Vivo by Embryonic Stem Cell-Derived Dendritic Cells Expressing Chemokine Along with Antigenic Protein: Application to Antitumor Vaccination1 , 2004, The Journal of Immunology.

[44]  M. Lyon,et al.  A dominant mutation within the DNA-binding domain of the bZIP transcription factor Maf causes murine cataract and results in selective alteration in DNA binding. , 2003, Human molecular genetics.

[45]  J. Kirkwood,et al.  Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or Melanoma , 2002, The Journal of experimental medicine.

[46]  Z. Cai,et al.  Early Antigen-Specific Response by Naive CD8 T Cells Is Not Altered with Aging1 , 2002, The Journal of Immunology.

[47]  L. Glimcher,et al.  Transcription: tantalizing times for T cells. , 2002, Cell.

[48]  E. Fikrig,et al.  Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. , 2000, Immunity.

[49]  T. Kita,et al.  Altered Th1/Th2 commitment in human CD4+ T cells with ageing , 2000, Clinical and experimental immunology.

[50]  S. Swain,et al.  Interleukin 2, but Not Other Common γ Chain–Binding Cytokines, Can Reverse the Defect in Generation of Cd4 Effector T Cells from Naive T Cells of Aged Mice , 1999, The Journal of experimental medicine.

[51]  L. Glimcher,et al.  c-maf Promotes T Helper Cell Type 2 (Th2) and Attenuates Th1 Differentiation by Both Interleukin 4–dependent and –independent Mechanisms , 1998, The Journal of experimental medicine.

[52]  C. Melief,et al.  Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors , 1998, The Journal of experimental medicine.

[53]  Y. Iwakura,et al.  Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. , 1997, Journal of immunology.

[54]  E. Wolf,et al.  The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL- 6 and prolongation of the plasma half-life of IL-6 , 1996, The Journal of experimental medicine.

[55]  K. Rock,et al.  Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity , 1995, Nature Medicine.

[56]  M. Passeri,et al.  Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. , 1993, Blood.